CV Lattes
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biomédicas from Universidade de São Paulo (2019) and master's at Ciências Biológicas (Farmacologia) from Faculdade de Medicina de Ribeirão Preto (2021). , acting on the following subjects: hu-910, psychosis, cb2, psicose canabinóide cb2 hu-910 and psicose. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Drugs used to treat schizophrenia improve mainly the positive symptoms of the disease, have low tolerability, and high rates of discontinuation of treatment. Recent evidence suggests that the endocannabinoid system may be a new target for the treatment of this disorder. The cannabinoid receptor type 2 (CB2) can modulate dopaminergic neurotransmission and attenuate the effects of proinflam…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |